Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder

British Journal of Psychiatry

Volumn 181, Issue OCT., 2002, Pages 315-320

  Martenyi, Ferenc ^a   Brown, Eileen B ^a   Zhang, Harry ^a   Koke, Stephanie C ^a   Prakash, Apurva ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO;

ADULT; AGED; ANXIETY NEUROSIS; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; POSTTRAUMATIC STRESS DISORDER; RANDOMIZED CONTROLLED TRIAL; RELAPSE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DOUBLE-BLIND METHOD; FEMALE; FLUOXETINE; HUMANS; MALE; MIDDLE AGED; RECURRENCE; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0036794843     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.181.4.315     Document Type: Article

References (27)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). Washington, DC: APA.
2. Ballenger, J. C. (1999) Current treatments of the anxiety disorders in adults. Biological Psychiatry, 46, 1579-1594.
3. Blake, D. D., Weathers, F.W., Nagy, L. M., et al (1995) The development of a clinician administered PTSD scale. Journal of Traumatic Stress, 8, 75-90.
4. Brady, K., Pearlstein, T., Asnis, G. M., et al (2000) Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA, 283, 1837-1844.
5. Breslau, N., Davis, G. C., Andreski, P., et al (1991) Traumatic events and posttraumatic stress disorder in an urban population of young adults. Archives of General Psychiatry, 48, 216-222.
6. Connor, K. M., Sutherland, S. M., Tupler, L. A., et al (1999) Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study. British Journal of Psychiatry, 175, 17-22.
7. Davidson, J. & Colket, J. T. (1997) The eight-item treatment-outcome post-traumatic stress disorder scale: a brief measure to assess treatment outcome in post-traumatic stress disorder. International Clinical Psychopharmacology, 12, 41-45.
8. _, Hughes, D., Blazer, D. G., et al (1991) Posttraumatic stress disorder in the community: an epidemiological study. Psychological Medicine, 21, 713-721.
9. _, Book, S.W., Colket, J. T., et al (1997) Assessment of a new self-rating scale for post-traumatic stress disorder. Psychological Medicine, 27, 153-160.
10. _, Pearlstein, T., Londborg, P., et al (2001) Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. American Journal of Psychiatry, 158, 1974-1981.
11. Derogatis, L. R. (1983) SCL-90-R. Administration, Scoring, and Procedures, Manual II. Baltimore, MD: Clinical Psychometric Research.
12. Entsuah, A. R., Rudolph, R. L., Hackett, D., et al (1996) Efficacy of venlafaxine and placebo during long-term treatment of depression: a pooled analysis of relapse rates. International Clinical Psychopharmacology, 11, 137-145.
13. First, M. B., Spitzer, R. L., Gibbon, M., et al (1997) Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I).Washington, DC: American Psychiatric Press.
14. Frank, E., Kupfer, D. J., Perel, J. M., et al (1990) Three-year outcomes for maintenance therapies in recurrent depression. Archives of General Psychiatry, 47, 1093-1099.
15. Guy, W. (1976) ECDEU Assessment Manual for Psychopharmacology. Revised DHEW Pub. (ADM). Rockville, MD: National Institute for Mental Health, Psychopharmacology Research.
16. Hamilton, M. (1959) The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50-55.
17. Helzer, J. E., Robins, L. N., McEvoy, L. (1987) Posttraumatic stress disorder in the general population. Findings of the Epidemiologic Catchment Area survey. New England Journal of Medicine, 317, 1630-1634.
18. Kessler, R. C., Sonnega, A., Bromet, E., et al (1995) Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry, 52, 1048-1060.
19. Londborg, P. D., Hegel, M. T., Goldstein, S., et al (2001) Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment. Journal of Clinical Psychiatry, 62, 325-331.
20. Martenyi, F., Brown, E. B., Zhang, H., et al (2002) Fluoxetine versus placebo in posttraumatic stress disorder. Journal of Clinical Psychiatry, 63, 199-206.
21. Michelson, D., Pollack, M., Lydiard, R. B., et al (1999) Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group. British Journal of Psychiatry, 174, 213-218.
22. Montgomery, S. A. & Åsberg, M. (1979) A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382-389.
23. _, Dufour, H., Brion, S., et al (1988) The prophylactic efficacy of fluoxetine in unipolar depression. British Journal of Psychiatry, 153 (suppl. 3), 69-76.
24. Reimherr, F.W., Amsterdam, J. D., Quitkin, F. M., et al (1998) Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. American Journal of Psychiatry, 155, 1247-1253.
25. Rief, W. & Fichter, M. (1992) The Symptom Check List SCL-90-R and its ability to discriminate between dysthymia, anxiety disorders, and anorexia nervosa. Psychopathology, 25, 128-138.
26. Rosenbaum, J. F., Fava, M., Hoog, S. L., et al (1998) Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biological Psychiatry, 44, 77-87.
27. Tucker, P., Zaninelli, R., Yehuda, R., et al (2001) Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo controlled, flexible dosage trial. Journal of Clinical Psychiatry, 62, 860-868.